Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionSOL Capital Management CO
Latest Disclosed Ownership6,300 shares
Latest Disclosed Value $ 312,563
SOL Capital Management CO reports 41.49% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 24, 2026 - SOL Capital Management CO filed a 13F-HR form disclosing ownership of 6,300 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $330,246 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 10,768 shares of Bristol-Myers Squibb Company. The current value of the position is $298,840 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,300 -4,468 -41.49 313 0.1517
2026-01-30 2025-12-31 13F Bristol-Myers Squibb COM 110122108 10,768 1,500 16.18 1 0.0522
2025-10-29 2025-09-30 13F Bristol-Myers Squibb COM 110122108 9,268 550 6.31 0 0.0375
2025-07-22 2025-06-30 13F Bristol-Myers Squibb COM 110122108 8,718 0 0.00 0 0.0392
2025-04-23 2025-03-31 13F Bristol-Myers Squibb COM 110122108 8,718 300 3.56 1 0.0586
2025-01-23 2024-12-31 13F Bristol-Myers Squibb COM 110122108 8,418 -3,600 -29.96 0 0.0530
2024-10-22 2024-09-30 13F Bristol-Myers Squibb COM 110122108 12,018 -600 -4.76 1 0.0691
2024-07-23 2024-06-30 13F Bristol-Myers Squibb COM 110122108 12,618 530 4.38 1 0.0629
2024-04-24 2024-03-31 13F Bristol-Myers Squibb COM 110122108 12,088 0 0.00 1 0.0825
2024-01-25 2023-12-31 13F Bristol-Myers Squibb COM 110122108 12,088 100 0.83 1 0.0842
2023-10-19 2023-09-30 13F Bristol-Myers Squibb COM 110122108 11,988 -200 -1.64 1 0.1078
2023-07-26 2023-06-30 13F Bristol-Myers Squibb COM 110122108 12,188 -500 -3.94 1 -100.00 0.1180
2023-04-19 2023-03-31 13F Bristol-Myers Squibb COM 110122108 12,688 -100 -0.78 879 -4.46 0.1441
2023-01-24 2022-12-31 13F Bristol-Myers Squibb COM 110122108 12,788 -140 -1.08 920 0.11 0.1628
2022-10-12 2022-09-30 13F Bristol-Myers Squibb COM 110122108 12,928 -185 -1.41 919 -9.01 0.1911
2022-07-21 2022-06-30 13F Bristol-Myers Squibb COM 110122108 13,113 -725 -5.24 1,010 -0.10 0.2045
2022-04-18 2022-03-31 13F Bristol-Myers Squibb COM 110122108 13,838 -850 -5.79 1,011 10.37 0.1826
2022-01-19 2021-12-31 13F Bristol-Myers Squibb COM 110122108 14,688 -200 -1.34 916 3.97 0.1656
2021-10-26 2021-09-30 13F Bristol-Myers Squibb COM 110122108 14,888 -375 -2.46 881 -13.63 0.1753
2021-07-20 2021-06-30 13F Bristol-Myers Squibb COM 110122108 15,263 -300 -1.93 1,020 3.87 0.2019
2021-04-22 2021-03-31 13F Bristol-Myers Squibb COM 110122108 15,563 -1,100 -6.60 982 -5.03 0.2072
2021-01-22 2020-12-31 13F Bristol-Myers Squibb COM 110122108 16,663 -100 -0.60 1,034 2.27 0.2409
2020-10-23 2020-09-30 13F Bristol-Myers Squibb COM 110122108 16,763 -50 -0.30 1,011 2.22 0.2781
2020-07-31 2020-06-30 13F Bristol-Myers Squibb COM 110122108 16,813 -14 -0.08 989 5.44 0.2800
2020-04-22 2020-03-31 13F Bristol-Myers Squibb COM 110122108 16,827 -700 -3.99 938 -16.62 0.3102
2020-01-27 2019-12-31 13F Bristol-Myers Squibb COM 110122108 17,527 80 0.46 1,125 27.12 0.2838
2019-10-21 2019-09-30 13F Bristol-Myers Squibb COM 110122108 17,447 -1,250 -6.69 885 4.36 0.2416
2019-07-17 2019-06-30 13F Bristol-Myers Squibb COM 110122108 18,697 0 0.00 848 -4.93 0.2305
2019-04-30 2019-03-31 13F Bristol-Myers Squibb COM 110122108 18,697 -350 -1.84 892 -9.90 0.2483
2019-01-25 2018-12-31 13F Bristol-Myers Squibb COM 110122108 19,047 0 0.00 990 -16.24 0.3165
2018-10-29 2018-09-30 13F Bristol-Myers Squibb COM 110122108 19,047 0 0.00 1,182 12.14 0.3191
2018-07-11 2018-06-30 13F Bristol-Myers Squibb COM 110122108 19,047 125 0.66 1,054 -11.95 0.3005
2018-04-24 2018-03-31 13F Bristol-Myers Squibb COM 110122108 18,922 -533 -2.74 1,197 0.42 0.3437
2018-01-31 2017-12-31 13F Bristol-Myers Squibb COM 110122108 19,455 -4,300 -18.10 1,192 -21.27 0.3406
2017-10-27 2017-09-30 13F Bristol-Myers Squibb COM 110122108 23,755 -700 -2.86 1,514 11.08 0.4271
2017-07-21 2017-06-30 13F Bristol-Myers Squibb COM 110122108 24,455 883 3.75 1,363 6.32 0.3747
2017-04-11 2017-03-31 13F Bristol-Myers Squibb COM 110122108 23,572 1,550 7.04 1,282 -0.39 0.3639
2017-01-30 2016-12-31 13F Bristol-Myers Squibb COM 110122108 22,022 5,182 30.77 1,287 41.74 0.3869
2016-11-01 2016-09-30 13F Bristol-Myers Squibb COM 110122108 16,840 560 3.44 908 -24.14 0.3040
2016-07-28 2016-06-30 13F Bristol-Myers Squibb COM 110122108 16,280 -1,000 -5.79 1,197 8.42 0.3986
2016-05-02 2016-03-31 13F Bristol-Myers Squibb COM 110122108 17,280 0 0.00 1,104 -7.15 0.3745
2016-02-01 2015-12-31 13F Bristol-Myers Squibb COM 110122108 17,280 -190 -1.09 1,189 14.99 0.4219
2015-11-04 2015-09-30 13F Bristol-Myers Squibb COM 110122108 17,470 -1,100 -5.92 1,034 -16.34 0.3991
2015-07-30 2015-06-30 13F Bristol-Myers Squibb COM 110122108 18,570 -205 -1.09 1,236 2.06 0.4518
2015-05-01 2015-03-31 13F Bristol-Myers Squibb COM 110122108 18,775 18,775 0.00 1,211 0.4451
2015-01-29 2014-12-31 13F Bristol-Myers Squibb COM 110122108 0 -19,250 -100.00 0 -100.00
2014-10-30 2014-09-30 13F Bristol-Myers Squibb COM 110122108 19,250 -1,100 -5.41 985 -0.20 0.4082
2014-08-01 2014-06-30 13F Bristol-Myers Squibb COM 110122108 20,350 0 0.00 987 -6.62 0.3946
2014-04-25 2014-03-31 13F Bristol-Myers Squibb COM 110122108 20,350 -100 -0.49 1,057 -2.76 0.4128
2014-02-04 2013-12-31 13F Bristol-Myers Squibb COM 110122108 20,450 -966 -4.51 1,087 9.69 0.4170
2013-10-10 2013-09-30 13F Bristol-Myers Squibb COM 110122108 21,416 -1,512 -6.59 991 -3.32 0.4106
2013-08-08 2013-06-30 13F Bristol-Myers Squibb COM 110122108 22,928 22,928 1,025 0.4169
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.